Thailand is currently in the process of gathering public opinions on a draft law that could bring about a significant shift in the regulation of cannabis use. This move follows over a year of thriving marijuana-related businesses in the country after the 2021 decriminalization, which initially lacked proper regulation.
As the first Southeast Asian nation to decriminalize cannabis, Thailand saw the emergence of a potentially lucrative industry, projected to be worth up to $1.2 billion. However, the present government is proposing stringent measures to restrict cannabis use exclusively to medical and health-related contexts.
The January 2024 draft bill seeks to address legal uncertainties arising from the initial decriminalization, aligning with Prime Minister Srettha Thavisin’s commitment to limiting cannabis use primarily to prevent addiction risks. Health Minister Cholnan Srikaew emphasized the necessity of prohibiting the “wrong usage of cannabis,” signaling a departure from hasty and piecemeal regulations that left room for recreational use.
This proposed regulation underscores a delicate balance between the recognized medical benefits and potential health risks associated with cannabis use. While cannabis has demonstrated efficacy in treating certain conditions, Thailand’s decision to re-regulate, specifically banning recreational use, is driven by health concerns, including addiction, mental health impacts, and public safety issues related to impaired driving.
The draft bill outlines strict penalties to enforce the new regulations. For recreational use, fines can reach up to 60,000 baht (approximately 1,700 USD), and advertising or marketing campaigns for recreational cannabis could result in jail terms or fines as high as 100,000 baht (~2,900 USD). Additionally, unlicensed cannabis farming faces intensified punishment, including jail terms of one to three years and fines ranging from 20,000 baht (~600 USD) to 300,000 baht (~8,600 USD).
Thailand’s proposed cannabis legislation is poised to reshape the country’s cannabis industry significantly, originally predicted to be worth 1.2 billion USD. By restricting cannabis use to medical and health purposes, the regulations are likely to contract this booming market. The fate of unregulated weed shops and dispensaries remains uncertain, as does the situation for those cultivating cannabis on a household scale.
The government has opened a feedback window until January 23, allowing stakeholders, including the cannabis industry and the public, to voice their opinions and concerns. Following this period, the Cabinet will review the feedback before presenting it to Parliament for further deliberation. The anticipated finalization and implementation of the legislation around March or April 2024 will mark a significant milestone in Thailand’s approach to cannabis regulation, potentially setting a precedent for other countries in the region.
Thailand’s journey from decriminalizing to potentially re-regulating cannabis highlights a cautious yet proactive approach to managing the plant’s potential benefits against its risks, prioritizing health and safety. This approach may offer valuable insights for other nations grappling with similar challenges.
Recreational use of cannabis remains prohibited in Singapore; however, exceptions have been made for medicinal purposes under specific and exceptional circumstances in recent years. Despite this, cannabis has become more accessible to the public, including the youth, through various discretionary means. Click here to watch a video to find out how and why more youths are getting addicted to cannabis.
Links to sources:
https://www.reuters.com/world/asia-pacific/thailand-seeks-public-opinion-draft-end-recreational-cannabis-use-2024-01-10/
https://medicalchannelasia.com/thailand-seeks-to-restrict-cannabis-to-medical-use-in-latest-legislation/
Explore the extensive selection of products at POM Marketplace.
Login or Sign Up for an account today!
* Access to POM Marketplace is available to qualified healthcare professionals only.
Disclaimer: The information provided on this website is intended for educational purposes only, and while we strive for accuracy, POMConnect assumes no liability for errors or omissions. The opinions expressed in this article are those of the author and do not necessarily reflect the views or opinions of POMConnect or its affiliated organizations. The content should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider regarding any medical concerns. POMConnect not endorse specific treatments or external websites linked from this site. POM Marketplace is accessible exclusively to qualified healthcare professionals. Any unauthorized access or use by individuals who do not meet this criteria is prohibited.
